FRS3
Fibroblast growth factor receptor substrate 3
Also known as: FRS2B, FRS2beta, FRS3_HUMAN, SNT-2
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- O43559
- Gene
- FRS3
- Ensembl
- ENSG00000137218
- Chromosome
- 6
- Canonical length
- 492 aa
- Protein class
- Predicted intracellular proteins
OverviewNCBI Gene
This gene encodes a substrate for the fibroblast growth factor receptor. The encoded protein is found in the peripheral plasma membrane and links fibroblast growth factor receptor stimulation to activators of Ras. The encoded protein down-regulates extracellular regulated kinase 2 through direct binding. [provided by RefSeq, Jul 2013]
Canonical amino-acid sequenceUniProt
492 residues, UniProt reviewed canonical sequence.
>O43559|FRS3
1 MGSCCSCLNR DSVPDNHPTK FKVTNVDDEG VELGSGVMEL TQSELVLHLH RREAVRWPYL
61 CLRRYGYDSN LFSFESGRRC QTGQGIFAFK CSRAEEIFNL LQDLMQCNSI NVMEEPVIIT
121 RNSHPAELDL PRAPQPPNAL GYTVSSFSNG CPGEGPRFSA PRRLSTSSLR HPSLGEESTH
181 ALIAPDEQSH TYVNTPASED DHRRGRHCLQ PLPEGQAPFL PQARGPDQRD PQVFLQPGQV
241 KFVLGPTPAR RHMVKCQGLC PSLHDPPHHN NNNEAPSECP AQPKCTYENV TGGLWRGAGW
301 RLSPEEPGWN GLAHRRAALL HYENLPPLPP VWESQAQQLG GEAGDDGDSR DGLTPSSNGF
361 PDGEEDETPL QKPTSTRAAI RSHGSFPVPL TRRRGSPRVF NFDFRRPGPE PPRQLNYIQV
421 ELKGWGGDRP KGPQNPSSPQ APMPTTHPAR SSDSYAVIDL KKTVAMSNLQ RALPRDDGTA
481 RKTRHNSTDL PLLocalizationUniProt · AlphaFold · HPA
Whether an antibody against FRS3 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.61
- Highest tissue expression
- 28 nTPM
Expression across tissuesHPA
Tissue
- cerebellum: 28 nTPM
- cerebral cortex: 24 nTPM
- hypothalamus: 21 nTPM
- hippocampal formation: 18 nTPM
- amygdala: 17 nTPM
- testis: 17 nTPM
Single-cell type
- epicardial cells: 116 nCPM
- cardiomyocytes: 31 nCPM
- adrenal medulla cells: 21 nCPM
- vascular endothelial cells: 20 nCPM
- retinal ganglion cells: 19 nCPM
- early primary spermatocytes: 15 nCPM
Immune cell
- eosinophil: 0.4 nTPM
- classical monocyte: 0.3 nTPM
- NK-cell: 0.3 nTPM
- plasmacytoid DC: 0.3 nTPM
- memory CD4 T-cell: 0.2 nTPM
- myeloid DC: 0.2 nTPM
Brain region
- cerebral cortex: 43 nTPM
- white matter: 33 nTPM
- pons: 30 nTPM
- basal ganglia: 27 nTPM
- amygdala: 26 nTPM
- medulla oblongata: 26 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.46
- gnomAD pLI
- 0.55
- gnomAD missense Z
- 0.92
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 7% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- fibroblast growth factor receptor binding
- identical protein binding
- transmembrane receptor protein tyrosine kinase adaptor activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of FRS3 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads FRS3 as an antibody target. Whether an autoantibody or antibody against FRS3 could matter depends on whether native FRS3 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
FRS3 is annotated at the cell surface, where native FRS3 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label FRS3 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...